海福德集團(00442.HK):要約人精益集團完成出售8.3萬股 公眾持股量恢復
格隆匯12月22日丨海福德集團(00442.HK)公佈,緊隨要約截止後,待過户登記處正式登記轉讓已收取有效接納相關的要約股份後,公眾持有43,067,506股股份(佔公司於截止公佈日期的全部已發行股本約24.95%)。因此,於截止公佈日期,公司未能符合上市規則第8.08(1)(a)條所載25%的最低公眾持股量規定。
公司已接獲要約人精益集團通知,要約人已向獨立第三方出售8.3萬股股份(佔公司於公佈日期的全部已發行股份約0.05%)。據董事在作出一切合理查詢後所深知、盡悉及確信,買方並非公司的核心關連人士,併為公眾人士。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.